Related Experiment Video
Updated: Aug 15, 2026

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells
Published on: March 28, 2013
Blunted glucose-induced thermogenesis: a factor contributing to relapse of obesity
1Diabetes Unit, University Hospital, Geneva, Switzerland.
Abstract:
It is well established that the long-term effect of weight-reducing diet therapies is disappointing, since the majority of those overweight regain their previous body weight regardless of the procedure used to maintain weight reduction. Glucose-Induced-Thermogenesis (GIT) was shown to be diminished in 55 obese patients particularly in the presence of insulin resistance (r = 0.44 p < 0.001) and in obese diabetic patients (3.7 +/- 0.7% vs 8.6 +/- 0.9% p < 0.001). After weight loss the combined effect of a decreased basal energy expenditure and an attenuation of GIT resulted in a postprandial energy expenditure which was markedly lower than in the overweight state (1.48 +/- 0.10 Kcal/min vs 1.15 +/- 0.05 Kcal/min p < 0.01). With six years evolution of obesity, GIT decreased significantly in non-diabetic obese (6.8 +/- 1.1% before and 4.1 +/- 0.8% after 6 years evolution p < 0.05) and was still blunted in the diabetic group (3.1 +/- 0.8% before and 2.1 +/- 0.7% after). The decrease in GIT was accompanied by reduction in glucose tolerance and insulin response. In conclusion, the decrease in GIT after weight loss and after six-years evolution of obesity, which accompanies the worsening of glucose tolerance and occurrence of diabetes, is a mechanism which may contribute to maintain the obese state by a reduction of energy expenditure.
More Related Videos
08:47Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
04:54Using a Combination of Indirect Calorimetry, Infrared Thermography, and Blood Glucose Levels to Measure Brown Adipose Tissue Thermogenesis in Humans
Published on: June 2, 2023
Related Concept Videos
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Hypoglycemia and Glucagon
Type II Diabetes II: Pathophysiology
Hyperglycemia